Specialty Pharmacy

ASHEVILLE, N.C. — ScriptCycle, a technology company that serves pharmacies and patients, will launch its comprehensive cash solutions for retail pharmacies at the NACDS Regional Conference in February. The products aim to help pharmacies address challenges related to their cash prescription business, the company said.

ScriptCycle said its business model has produced average per-store savings of $7,000 to $12,000 per year.

KINGSTON, R.I. — The National Institutes of Health have awarded a University of Rhode Island pharmacy professor a $1.3 million grant to further study a new class of inorganic nanoparticles that target primary cancer and help control the disease’s spread and recurrence.



FLORHAM PARK, N.J. — Armada Health Care on Thursday added featured speaker Myrtle Potter to its card at the 2014 Specialty Pharmacy Summit and Expo to be held in Las Vegas May 5 to 9. The specialty pharmacy group also announced the addition of a pre-conference seminar/workshop to take place on May 5 and 6. 

Potter will join a speaker faculty of more than 50 other industry experts at this conference with a presentation titled, "Healthcare Leaders: How Will You Successfully Navigate the Healthcare Storm?". 

ROGERS, Ark. — Walmart health-and-wellness president John Agwunobi shared wide-ranging thoughts regarding the state of health care in America and ways in which the evolving marketplace is impacting Walmart customers.
 

BOSTON — Researchers from Massachusetts Eye and Ear, Harvard Medical School, Massachusetts Institute of Technology and Massachusetts General Hospital have demonstrated that aspirin intake correlates with halted growth of vestibular schwannomas, also known as acoustic neuromas, a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus.

DUBLIN — Perrigo Co. announced that it received final approval from the Food and Drug Administration for repaglinide tablets — a generic version of Prandin tablets — in 1-mg and 2-mg strengths. The company has started shipment of the drug. Perrigo previously launched the 0.5-mg strength in 2013.

AMITYVILLE, N.Y. — Hi-Tech Pharmacal Co., a specialty pharmaceuticals company, on Thursday announced that it was granted final approval from the Food and Drug Administration for bromfenac ophthalmic solution 0.09% (once-a-day), a generic version of ISTA Pharmaceuticals’ Bromday ophthalmic solution, 0.09%.

The product is used to treat post-op inflammation and reduction of ocular pain in patients who have had cataract surgery. The company plans to launch the product immediately.

SACRAMENTO, Calif. — Assembly Member Richard Bloom, D-Santa Monica, on Tuesday introduced legislation that would authorize a pharmacist to dispense the narcotic antagonist naloxone hydrochloride without a prescription in California. 

Naloxone is used to treat overdoses of narcotic medications including morphine, codeine and oxycodone and works by reversing the side effects of the narcotic, such as sedation and decreased breathing rate.